Status:
COMPLETED
Effectiveness Study of Atrial Fibrillation
Lead Sponsor:
La-ser Europe Limited
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
This is an international observational multicentre study to be conducted in Germany, Spain, Italy and USA. The main objective of the study is to evaluate the relative effectiveness of dronedarone in r...
Eligibility Criteria
Inclusion
- Patient 18 years old or above
- Patient with paroxysmal or persistent atrial fibrillation
- Patient using an AAi (antiarrhythmic drug of interest) or dronedarone (index drug)
- Patient's treatment changed from one AAi to another AAi or dronedarone OR from no antiarrhythmic therapy to the start of AAi or dronedarone therapy during previous 6 months before the date of recruitment
- Patient with at least 6 months of medical and treatment information prior to the start of the index drug
- Patient able to answer the telephone interview in a language of the participating country: English, German, Italian or Spanish (with or without proxy).
Exclusion
- Patient with heart failure (NYHA class IV)
- Patient with permanent Atrial Fibrillation
- Patient with psychiatric conditions preventing the participation to the study according to the physician
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
1015 Patients enrolled
Trial Details
Trial ID
NCT01856075
Start Date
October 1 2012
End Date
August 1 2015
Last Update
September 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Praxis fuer Kardiologie, Im Muehlenbach 2B
Bonn, Germany, 53127